

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pigment cell differentiation (GO:0050931) | 9.88500470 |
| 2 | melanosome organization (GO:0032438) | 8.53131198 |
| 3 | pigment granule organization (GO:0048753) | 8.13426585 |
| 4 | melanin biosynthetic process (GO:0042438) | 7.69162750 |
| 5 | melanin metabolic process (GO:0006582) | 7.50151535 |
| 6 | pigment biosynthetic process (GO:0046148) | 7.15443158 |
| 7 | secondary metabolite biosynthetic process (GO:0044550) | 6.39408252 |
| 8 | pigment metabolic process (GO:0042440) | 5.65294499 |
| 9 | endosome to pigment granule transport (GO:0043485) | 5.47439767 |
| 10 | endosome to melanosome transport (GO:0035646) | 5.47439767 |
| 11 | pigmentation (GO:0043473) | 5.00804893 |
| 12 | ketone body metabolic process (GO:1902224) | 4.85819347 |
| 13 | melanosome transport (GO:0032402) | 4.30005872 |
| 14 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 4.22303856 |
| 15 | establishment of melanosome localization (GO:0032401) | 4.20969187 |
| 16 | melanosome localization (GO:0032400) | 4.20858880 |
| 17 | developmental pigmentation (GO:0048066) | 4.12083455 |
| 18 | positive regulation of neuroblast proliferation (GO:0002052) | 4.10737627 |
| 19 | pigment granule transport (GO:0051904) | 4.05319494 |
| 20 | pigment granule localization (GO:0051875) | 3.99500747 |
| 21 | establishment of pigment granule localization (GO:0051905) | 3.97749029 |
| 22 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.92037249 |
| 23 | retinal rod cell development (GO:0046548) | 3.91895352 |
| 24 | platelet dense granule organization (GO:0060155) | 3.65676110 |
| 25 | phenol-containing compound metabolic process (GO:0018958) | 3.64434461 |
| 26 | microtubule depolymerization (GO:0007019) | 3.62465048 |
| 27 | enteric nervous system development (GO:0048484) | 3.60854912 |
| 28 | cullin deneddylation (GO:0010388) | 3.58598637 |
| 29 | cellular response to nitric oxide (GO:0071732) | 3.53791079 |
| 30 | protein neddylation (GO:0045116) | 3.44950792 |
| 31 | intraciliary transport (GO:0042073) | 3.44076116 |
| 32 | DNA ligation (GO:0006266) | 3.42559252 |
| 33 | 7-methylguanosine mRNA capping (GO:0006370) | 3.40013047 |
| 34 | RNA capping (GO:0036260) | 3.37917849 |
| 35 | 7-methylguanosine RNA capping (GO:0009452) | 3.37917849 |
| 36 | cellular response to reactive nitrogen species (GO:1902170) | 3.32228367 |
| 37 | protein deneddylation (GO:0000338) | 3.30492873 |
| 38 | proline transport (GO:0015824) | 3.29898344 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 3.27565124 |
| 40 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.26770851 |
| 41 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.24527009 |
| 42 | proteasome assembly (GO:0043248) | 3.17376204 |
| 43 | presynaptic membrane assembly (GO:0097105) | 3.15929128 |
| 44 | kinetochore organization (GO:0051383) | 3.13226727 |
| 45 | protein-cofactor linkage (GO:0018065) | 3.12158480 |
| 46 | DNA damage response, detection of DNA damage (GO:0042769) | 3.09276045 |
| 47 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.08036791 |
| 48 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.08036791 |
| 49 | limb bud formation (GO:0060174) | 3.07356140 |
| 50 | sympathetic nervous system development (GO:0048485) | 3.06604395 |
| 51 | cornea development in camera-type eye (GO:0061303) | 3.05181005 |
| 52 | positive regulation of mitochondrial fission (GO:0090141) | 3.04779781 |
| 53 | phenol-containing compound biosynthetic process (GO:0046189) | 3.04712011 |
| 54 | CENP-A containing nucleosome assembly (GO:0034080) | 3.03519414 |
| 55 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.00447729 |
| 56 | inositol phosphate dephosphorylation (GO:0046855) | 3.00447729 |
| 57 | keratinocyte development (GO:0003334) | 2.99140334 |
| 58 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.97162748 |
| 59 | myotube differentiation (GO:0014902) | 2.96846538 |
| 60 | short-chain fatty acid metabolic process (GO:0046459) | 2.96158643 |
| 61 | DNA double-strand break processing (GO:0000729) | 2.95766220 |
| 62 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.95715411 |
| 63 | acrosome reaction (GO:0007340) | 2.93383762 |
| 64 | kinetochore assembly (GO:0051382) | 2.92638209 |
| 65 | peripheral nervous system development (GO:0007422) | 2.90855537 |
| 66 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.90489535 |
| 67 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.90489535 |
| 68 | startle response (GO:0001964) | 2.88309549 |
| 69 | dopamine transport (GO:0015872) | 2.87684497 |
| 70 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.87376715 |
| 71 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.84627888 |
| 72 | viral mRNA export from host cell nucleus (GO:0046784) | 2.84062423 |
| 73 | microtubule polymerization or depolymerization (GO:0031109) | 2.83784486 |
| 74 | negative regulation of dendrite development (GO:2000171) | 2.82450192 |
| 75 | viral protein processing (GO:0019082) | 2.81213727 |
| 76 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.80930724 |
| 77 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.80765055 |
| 78 | presynaptic membrane organization (GO:0097090) | 2.80413762 |
| 79 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.77615614 |
| 80 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.76378645 |
| 81 | termination of RNA polymerase III transcription (GO:0006386) | 2.76378645 |
| 82 | chromatin remodeling at centromere (GO:0031055) | 2.75928350 |
| 83 | neuroepithelial cell differentiation (GO:0060563) | 2.75745883 |
| 84 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.75215043 |
| 85 | regulation of early endosome to late endosome transport (GO:2000641) | 2.74997028 |
| 86 | histone H2A acetylation (GO:0043968) | 2.72911292 |
| 87 | inositol phosphate catabolic process (GO:0071545) | 2.72350295 |
| 88 | centrosome duplication (GO:0051298) | 2.71352122 |
| 89 | transcription from RNA polymerase I promoter (GO:0006360) | 2.71026538 |
| 90 | chaperone-mediated protein transport (GO:0072321) | 2.70433701 |
| 91 | protein complex biogenesis (GO:0070271) | 2.69286292 |
| 92 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.66337109 |
| 93 | maturation of 5.8S rRNA (GO:0000460) | 2.65990467 |
| 94 | termination of RNA polymerase I transcription (GO:0006363) | 2.65869978 |
| 95 | regulation of neuroblast proliferation (GO:1902692) | 2.65514611 |
| 96 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.64657083 |
| 97 | osteoclast differentiation (GO:0030316) | 2.62515093 |
| 98 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.61181727 |
| 99 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.61102230 |
| 100 | embryonic body morphogenesis (GO:0010172) | 2.60500306 |
| 101 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.60136155 |
| 102 | negative regulation of mast cell activation (GO:0033004) | 2.59797288 |
| 103 | neuron cell-cell adhesion (GO:0007158) | 2.57783598 |
| 104 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.57087798 |
| 105 | sialylation (GO:0097503) | 2.56081984 |
| 106 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.54779739 |
| 107 | cellular response to oxygen radical (GO:0071450) | 2.54762619 |
| 108 | removal of superoxide radicals (GO:0019430) | 2.54762619 |
| 109 | cellular response to superoxide (GO:0071451) | 2.54762619 |
| 110 | response to nitric oxide (GO:0071731) | 2.53688475 |
| 111 | polyol catabolic process (GO:0046174) | 2.52338454 |
| 112 | nonmotile primary cilium assembly (GO:0035058) | 2.51570718 |
| 113 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.51519392 |
| 114 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.50075036 |
| 115 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.49548450 |
| 116 | secretory granule organization (GO:0033363) | 2.48747822 |
| 117 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.48270909 |
| 118 | NADH dehydrogenase complex assembly (GO:0010257) | 2.46964234 |
| 119 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.46964234 |
| 120 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.46964234 |
| 121 | respiratory chain complex IV assembly (GO:0008535) | 2.46725342 |
| 122 | ER overload response (GO:0006983) | 2.46427748 |
| 123 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.45036341 |
| 124 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.45036341 |
| 125 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.45036341 |
| 126 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.44978355 |
| 127 | postsynaptic membrane organization (GO:0001941) | 2.44814834 |
| 128 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.44801221 |
| 129 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.44752623 |
| 130 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.44356622 |
| 131 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.43515712 |
| 132 | ganglion development (GO:0061548) | 2.42901505 |
| 133 | secondary metabolic process (GO:0019748) | 2.42493708 |
| 134 | regulation of superoxide anion generation (GO:0032928) | 2.42455360 |
| 135 | protein localization to microtubule (GO:0035372) | 2.42047890 |
| 136 | mannosylation (GO:0097502) | 2.41794825 |
| 137 | regulation of pigment cell differentiation (GO:0050932) | 2.41308568 |
| 138 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.41180885 |
| 139 | cGMP-mediated signaling (GO:0019934) | 2.39960827 |
| 140 | cell differentiation involved in metanephros development (GO:0072202) | 2.39816748 |
| 141 | signal peptide processing (GO:0006465) | 2.37742286 |
| 142 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.37298430 |
| 143 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.37298430 |
| 144 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.37180110 |
| 145 | centriole replication (GO:0007099) | 2.36855504 |
| 146 | cytochrome complex assembly (GO:0017004) | 2.35757506 |
| 147 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.35251201 |
| 148 | plasma membrane fusion (GO:0045026) | 2.34997745 |
| 149 | negative regulation of glycogen metabolic process (GO:0070874) | 2.34996205 |
| 150 | negative regulation of macroautophagy (GO:0016242) | 2.34629077 |
| 151 | positive regulation of amino acid transport (GO:0051957) | 2.34437558 |
| 152 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.33676957 |
| 153 | vesicle localization (GO:0051648) | 2.33463362 |
| 154 | DNA-templated transcription, elongation (GO:0006354) | 2.33431794 |
| 155 | centriole assembly (GO:0098534) | 2.32973130 |
| 156 | GTP biosynthetic process (GO:0006183) | 2.32718680 |
| 157 | negative regulation of JUN kinase activity (GO:0043508) | 2.32414974 |
| 158 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.31897808 |
| 159 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.31897808 |
| 160 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.29383961 |
| 161 | negative regulation of organelle assembly (GO:1902116) | 2.27786244 |
| 162 | piRNA metabolic process (GO:0034587) | 2.26516899 |
| 163 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.24076247 |
| 164 | response to pheromone (GO:0019236) | 2.21938259 |
| 165 | intracellular pH reduction (GO:0051452) | 2.17329956 |
| 166 | cranial nerve development (GO:0021545) | 2.17298468 |
| 167 | regulation of protein sumoylation (GO:0033233) | 2.17010250 |
| 168 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.16172799 |
| 169 | positive regulation of response to oxidative stress (GO:1902884) | 2.16172799 |
| 170 | astrocyte differentiation (GO:0048708) | 2.14997661 |
| 171 | positive regulation of neural precursor cell proliferation (GO:2000179) | 2.12470490 |
| 172 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.10961491 |
| 173 | negative regulation of chemokine production (GO:0032682) | 2.10767543 |
| 174 | positive regulation of receptor recycling (GO:0001921) | 2.09114701 |
| 175 | synaptic transmission, cholinergic (GO:0007271) | 2.08717710 |
| 176 | dendritic spine organization (GO:0097061) | 2.07076658 |
| 177 | regulation of penile erection (GO:0060405) | 2.05693455 |
| 178 | alanine transport (GO:0032328) | 2.05536578 |
| 179 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.03789609 |
| 180 | behavioral response to ethanol (GO:0048149) | 2.03398665 |
| 181 | neural crest cell migration (GO:0001755) | 2.02639708 |
| 182 | layer formation in cerebral cortex (GO:0021819) | 2.02405782 |
| 183 | body morphogenesis (GO:0010171) | 2.02146913 |
| 184 | melanocyte differentiation (GO:0030318) | 10.1909497 |
| 185 | tyrosine metabolic process (GO:0006570) | 10.0025587 |
| 186 | basement membrane organization (GO:0071711) | 1.98889491 |
| 187 | dopamine biosynthetic process (GO:0042416) | 1.98768596 |
| 188 | neuron remodeling (GO:0016322) | 1.98675076 |
| 189 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.98316281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.93241975 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.34906493 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20995195 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.17070814 |
| 5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.49171434 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.39424009 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.39374469 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.35365374 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.32797868 |
| 10 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 2.19921188 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.18170288 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16159047 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.15003559 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.07851642 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.07455148 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.07319371 |
| 17 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.01577478 |
| 18 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.00038863 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96294787 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.94415640 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 1.92274764 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88196566 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88188769 |
| 24 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.86331734 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85429492 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.84346479 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.83147424 |
| 28 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77344615 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76408243 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75281187 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.73482424 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72932760 |
| 33 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.71737470 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71327503 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.70407516 |
| 36 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.68083891 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67481676 |
| 38 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.67417858 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67400045 |
| 40 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.66911392 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66294554 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.65990458 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61237735 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60885996 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60504218 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57206328 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.55368716 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54270346 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.53005581 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52640701 |
| 51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52501064 |
| 52 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.50484763 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.49432567 |
| 54 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48307043 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47123493 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.46483362 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46483362 |
| 58 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.45693545 |
| 59 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.45626790 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.45049472 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43544486 |
| 62 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43046775 |
| 63 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42456568 |
| 64 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42445362 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38393792 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37009131 |
| 67 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36816102 |
| 68 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.35823709 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35738517 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35285416 |
| 71 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.33232268 |
| 72 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.31782499 |
| 73 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.31469516 |
| 74 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30820150 |
| 75 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.29603980 |
| 76 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29283497 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29160231 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29044650 |
| 79 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.28927836 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28874398 |
| 81 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28325444 |
| 82 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27706788 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26700067 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26256628 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26256628 |
| 86 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25973459 |
| 87 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.24534083 |
| 88 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.24442937 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24346559 |
| 90 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24264764 |
| 91 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22670759 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22536838 |
| 93 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.21311778 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20468265 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20341107 |
| 96 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20094847 |
| 97 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18444562 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18067662 |
| 99 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17192792 |
| 100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16420654 |
| 101 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16293347 |
| 102 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.16104344 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16080572 |
| 104 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15556553 |
| 105 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.15318165 |
| 106 | JUN_21703547_ChIP-Seq_K562_Human | 1.15196976 |
| 107 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14933763 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14923473 |
| 109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14832927 |
| 110 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14772649 |
| 111 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14018778 |
| 112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13904070 |
| 113 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13838710 |
| 114 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12911548 |
| 115 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.12428375 |
| 116 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12162701 |
| 117 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11911082 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11371436 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.11059012 |
| 120 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08692764 |
| 121 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08029857 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07510822 |
| 123 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.06925109 |
| 124 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.06542408 |
| 125 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06023437 |
| 126 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.05197167 |
| 127 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05004345 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04958123 |
| 129 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03194746 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02721687 |
| 131 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02221270 |
| 132 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01886760 |
| 133 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01357193 |
| 134 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.00727634 |
| 135 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.99785103 |
| 136 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99429800 |
| 137 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99379066 |
| 138 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98190768 |
| 139 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97989319 |
| 140 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97887723 |
| 141 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97824461 |
| 142 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96883309 |
| 143 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.96256732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 6.02339607 |
| 2 | MP0005171_absent_coat_pigmentation | 5.63647832 |
| 3 | MP0003136_yellow_coat_color | 3.10639069 |
| 4 | MP0001188_hyperpigmentation | 3.02160457 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.84862512 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.84576955 |
| 7 | MP0003787_abnormal_imprinting | 2.53898517 |
| 8 | * MP0005408_hypopigmentation | 2.52618194 |
| 9 | MP0003880_abnormal_central_pattern | 2.44630453 |
| 10 | MP0000566_synostosis | 2.13703233 |
| 11 | * MP0000015_abnormal_ear_pigmentation | 2.07085091 |
| 12 | MP0002102_abnormal_ear_morphology | 1.99815657 |
| 13 | MP0001529_abnormal_vocalization | 1.94388957 |
| 14 | MP0005409_darkened_coat_color | 1.94071770 |
| 15 | MP0002938_white_spotting | 1.90415710 |
| 16 | MP0004381_abnormal_hair_follicle | 1.88668585 |
| 17 | * MP0002095_abnormal_skin_pigmentation | 1.86859459 |
| 18 | MP0002751_abnormal_autonomic_nervous | 1.81219285 |
| 19 | MP0008789_abnormal_olfactory_epithelium | 1.79542804 |
| 20 | MP0005646_abnormal_pituitary_gland | 1.79097887 |
| 21 | MP0009697_abnormal_copulation | 1.73878235 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.73766447 |
| 23 | MP0003121_genomic_imprinting | 1.68524626 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.68494481 |
| 25 | MP0002638_abnormal_pupillary_reflex | 1.64307280 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.62412165 |
| 27 | MP0000371_diluted_coat_color | 1.62118293 |
| 28 | MP0005394_taste/olfaction_phenotype | 1.61187179 |
| 29 | MP0005499_abnormal_olfactory_system | 1.61187179 |
| 30 | MP0003122_maternal_imprinting | 1.60468387 |
| 31 | MP0003718_maternal_effect | 1.59183879 |
| 32 | MP0008058_abnormal_DNA_repair | 1.56472249 |
| 33 | MP0003315_abnormal_perineum_morphology | 1.53374603 |
| 34 | MP0000778_abnormal_nervous_system | 1.50032622 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.41878943 |
| 36 | MP0002090_abnormal_vision | 1.41703277 |
| 37 | MP0002075_abnormal_coat/hair_pigmentati | 1.41245201 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.41082496 |
| 39 | MP0001984_abnormal_olfaction | 1.38096773 |
| 40 | * MP0001186_pigmentation_phenotype | 1.37247926 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.35780138 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.34633838 |
| 43 | MP0001905_abnormal_dopamine_level | 1.31931292 |
| 44 | MP0005257_abnormal_intraocular_pressure | 1.29192767 |
| 45 | MP0000631_abnormal_neuroendocrine_gland | 1.27186804 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.24784872 |
| 47 | MP0000049_abnormal_middle_ear | 1.22127582 |
| 48 | MP0003786_premature_aging | 1.21602414 |
| 49 | MP0003111_abnormal_nucleus_morphology | 1.21129526 |
| 50 | MP0005367_renal/urinary_system_phenotyp | 1.20299949 |
| 51 | MP0000516_abnormal_urinary_system | 1.20299949 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.18251622 |
| 53 | MP0002160_abnormal_reproductive_system | 1.16841399 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.12795737 |
| 55 | MP0003693_abnormal_embryo_hatching | 1.12366120 |
| 56 | MP0009745_abnormal_behavioral_response | 1.10296010 |
| 57 | MP0009046_muscle_twitch | 1.07749873 |
| 58 | MP0005389_reproductive_system_phenotype | 1.07010508 |
| 59 | MP0002184_abnormal_innervation | 1.06085296 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.05753278 |
| 61 | MP0008057_abnormal_DNA_replication | 1.05631275 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.04754024 |
| 63 | MP0004885_abnormal_endolymph | 1.04366162 |
| 64 | MP0002736_abnormal_nociception_after | 1.04271431 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.04191176 |
| 66 | MP0001177_atelectasis | 1.02528228 |
| 67 | MP0001919_abnormal_reproductive_system | 1.02275466 |
| 68 | * MP0001324_abnormal_eye_pigmentation | 1.01285926 |
| 69 | MP0003878_abnormal_ear_physiology | 1.01049266 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.01049266 |
| 71 | MP0001963_abnormal_hearing_physiology | 1.00872817 |
| 72 | MP0002063_abnormal_learning/memory/cond | 1.00201874 |
| 73 | MP0001968_abnormal_touch/_nociception | 0.98849194 |
| 74 | MP0000026_abnormal_inner_ear | 0.98660537 |
| 75 | * MP0005075_abnormal_melanosome_morpholog | 0.98492634 |
| 76 | MP0002734_abnormal_mechanical_nocicepti | 0.98352538 |
| 77 | MP0003077_abnormal_cell_cycle | 0.98332225 |
| 78 | MP0008260_abnormal_autophagy | 0.97549641 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.95984753 |
| 80 | * MP0005197_abnormal_uvea_morphology | 0.95918747 |
| 81 | MP0004924_abnormal_behavior | 0.94852294 |
| 82 | MP0005386_behavior/neurological_phenoty | 0.94852294 |
| 83 | MP0005253_abnormal_eye_physiology | 0.92256273 |
| 84 | MP0000681_abnormal_thyroid_gland | 0.92113821 |
| 85 | MP0008932_abnormal_embryonic_tissue | 0.91912361 |
| 86 | MP0002822_catalepsy | 0.91488087 |
| 87 | MP0004142_abnormal_muscle_tone | 0.90263893 |
| 88 | MP0002067_abnormal_sensory_capabilities | 0.89822160 |
| 89 | MP0003938_abnormal_ear_development | 0.89256553 |
| 90 | MP0002272_abnormal_nervous_system | 0.88556515 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.88448019 |
| 92 | MP0003172_abnormal_lysosome_physiology | 0.85563525 |
| 93 | MP0003635_abnormal_synaptic_transmissio | 0.85103448 |
| 94 | MP0001486_abnormal_startle_reflex | 0.84969595 |
| 95 | MP0002064_seizures | 0.83600333 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.81358016 |
| 97 | MP0009379_abnormal_foot_pigmentation | 0.80899371 |
| 98 | MP0004147_increased_porphyrin_level | 0.80861353 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.80646414 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.79533511 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.78521217 |
| 102 | * MP0002177_abnormal_outer_ear | 0.77539793 |
| 103 | MP0002163_abnormal_gland_morphology | 0.77107295 |
| 104 | MP0003385_abnormal_body_wall | 0.74949135 |
| 105 | MP0003890_abnormal_embryonic-extraembry | 0.72224117 |
| 106 | MP0002752_abnormal_somatic_nervous | 0.71418305 |
| 107 | MP0003937_abnormal_limbs/digits/tail_de | 0.70791594 |
| 108 | MP0004270_analgesia | 0.70677279 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.63400079 |
| 110 | MP0003646_muscle_fatigue | 0.55496578 |
| 111 | MP0000367_abnormal_coat/_hair | 0.51373717 |
| 112 | MP0005187_abnormal_penis_morphology | 0.50497364 |
| 113 | MP0005391_vision/eye_phenotype | 0.46278584 |
| 114 | MP0002837_dystrophic_cardiac_calcinosis | 0.41197256 |
| 115 | MP0001293_anophthalmia | 0.40743358 |
| 116 | MP0003186_abnormal_redox_activity | 0.36514152 |
| 117 | MP0000377_abnormal_hair_follicle | 0.35274233 |
| 118 | MP0000647_abnormal_sebaceous_gland | 0.35221778 |
| 119 | MP0002229_neurodegeneration | 0.34289470 |
| 120 | * MP0005193_abnormal_anterior_eye | 0.33706498 |
| 121 | MP0002089_abnormal_postnatal_growth/wei | 0.30963859 |
| 122 | MP0003567_abnormal_fetal_cardiomyocyte | 0.30638195 |
| 123 | MP0010030_abnormal_orbit_morphology | 0.30506085 |
| 124 | MP0003283_abnormal_digestive_organ | 0.30007754 |
| 125 | * MP0005195_abnormal_posterior_eye | 0.26532140 |
| 126 | MP0002092_abnormal_eye_morphology | 0.25624989 |
| 127 | MP0000920_abnormal_myelination | 0.23519817 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.23046112 |
| 129 | MP0003011_delayed_dark_adaptation | 0.21896120 |
| 130 | MP0005423_abnormal_somatic_nervous | 0.21367897 |
| 131 | MP0002697_abnormal_eye_size | 0.21286685 |
| 132 | MP0008569_lethality_at_weaning | 0.21214856 |
| 133 | MP0000749_muscle_degeneration | 0.21091496 |
| 134 | MP0003632_abnormal_nervous_system | 0.17743881 |
| 135 | MP0000358_abnormal_cell_content/ | 0.17392382 |
| 136 | MP0003634_abnormal_glial_cell | 0.15775329 |
| 137 | MP0008770_decreased_survivor_rate | 0.15183890 |
| 138 | MP0008438_abnormal_cutaneous_collagen | 0.15106954 |
| 139 | MP0003698_abnormal_male_reproductive | 0.13835262 |
| 140 | MP0000427_abnormal_hair_cycle | 0.12462541 |
| 141 | MP0001299_abnormal_eye_distance/ | 0.12311029 |
| 142 | MP0002233_abnormal_nose_morphology | 0.12212388 |
| 143 | MP0002109_abnormal_limb_morphology | 0.11038007 |
| 144 | MP0004133_heterotaxia | 0.10350136 |
| 145 | MP0000955_abnormal_spinal_cord | 0.10258385 |
| 146 | MP0006138_congestive_heart_failure | 0.09673963 |
| 147 | MP0004742_abnormal_vestibular_system | 0.09569699 |
| 148 | MP0003950_abnormal_plasma_membrane | 0.09188112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypopigmentation of the fundus (HP:0007894) | 6.59933169 |
| 2 | Albinism (HP:0001022) | 6.03078660 |
| 3 | Abnormal auditory evoked potentials (HP:0006958) | 4.64774879 |
| 4 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.38991704 |
| 5 | Hypoplasia of the fovea (HP:0007750) | 4.38991704 |
| 6 | Hypothermia (HP:0002045) | 4.03288486 |
| 7 | Hypoplasia of the iris (HP:0007676) | 3.86813131 |
| 8 | Blue irides (HP:0000635) | 3.80698014 |
| 9 | Abnormality of the fovea (HP:0000493) | 3.79398724 |
| 10 | Cutaneous melanoma (HP:0012056) | 3.68204378 |
| 11 | Abnormal hair whorl (HP:0010721) | 3.67049483 |
| 12 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.62446585 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.42986786 |
| 14 | Medial flaring of the eyebrow (HP:0010747) | 3.27918960 |
| 15 | Nephrogenic diabetes insipidus (HP:0009806) | 3.22065229 |
| 16 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.14991358 |
| 17 | Gait imbalance (HP:0002141) | 3.14073824 |
| 18 | True hermaphroditism (HP:0010459) | 3.12872410 |
| 19 | Congenital primary aphakia (HP:0007707) | 3.08893763 |
| 20 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.90586085 |
| 21 | White forelock (HP:0002211) | 2.82873968 |
| 22 | Poor coordination (HP:0002370) | 2.74658582 |
| 23 | Patchy hypopigmentation of hair (HP:0011365) | 2.68322081 |
| 24 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.66464978 |
| 25 | Pancreatic cysts (HP:0001737) | 2.64823131 |
| 26 | Spastic paraparesis (HP:0002313) | 2.62705225 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.60127187 |
| 28 | Heterochromia iridis (HP:0001100) | 2.59724960 |
| 29 | Preaxial hand polydactyly (HP:0001177) | 2.51471913 |
| 30 | Febrile seizures (HP:0002373) | 2.47400054 |
| 31 | Genital tract atresia (HP:0001827) | 2.41201201 |
| 32 | Intestinal atresia (HP:0011100) | 2.40434815 |
| 33 | Birth length less than 3rd percentile (HP:0003561) | 2.38703133 |
| 34 | Vaginal atresia (HP:0000148) | 2.36329763 |
| 35 | Chromsome breakage (HP:0040012) | 2.35757583 |
| 36 | Abnormality of the labia minora (HP:0012880) | 2.34851825 |
| 37 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.32297723 |
| 38 | Type I transferrin isoform profile (HP:0003642) | 2.31882551 |
| 39 | Peripheral hypomyelination (HP:0007182) | 2.31754218 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.31172737 |
| 41 | Patellar aplasia (HP:0006443) | 2.30784612 |
| 42 | Embryonal renal neoplasm (HP:0011794) | 2.30104027 |
| 43 | Atonic seizures (HP:0010819) | 2.29126900 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.26501399 |
| 45 | Hyperventilation (HP:0002883) | 2.26291874 |
| 46 | Abnormal lung lobation (HP:0002101) | 2.24722576 |
| 47 | Amblyopia (HP:0000646) | 2.22985306 |
| 48 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.20246595 |
| 49 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.19401530 |
| 50 | Generalized hypopigmentation of hair (HP:0011358) | 2.18961434 |
| 51 | Protruding tongue (HP:0010808) | 2.18928617 |
| 52 | Aganglionic megacolon (HP:0002251) | 2.18726234 |
| 53 | Congenital stationary night blindness (HP:0007642) | 2.18191146 |
| 54 | Postaxial foot polydactyly (HP:0001830) | 2.17599913 |
| 55 | Osteomalacia (HP:0002749) | 2.16812400 |
| 56 | Chronic hepatic failure (HP:0100626) | 2.14096508 |
| 57 | Focal motor seizures (HP:0011153) | 2.12753066 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11546365 |
| 59 | Molar tooth sign on MRI (HP:0002419) | 2.11375677 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.11375677 |
| 61 | Premature graying of hair (HP:0002216) | 2.11119992 |
| 62 | Degeneration of anterior horn cells (HP:0002398) | 1.98873246 |
| 63 | Abnormality of the anterior horn cell (HP:0006802) | 1.98873246 |
| 64 | Occipital encephalocele (HP:0002085) | 1.98289000 |
| 65 | Large for gestational age (HP:0001520) | 1.97938404 |
| 66 | Mitochondrial inheritance (HP:0001427) | 1.96866373 |
| 67 | Iris hypopigmentation (HP:0007730) | 1.95060036 |
| 68 | Abnormality of incisor morphology (HP:0011063) | 1.94922995 |
| 69 | Paraparesis (HP:0002385) | 1.93564394 |
| 70 | Increased CSF lactate (HP:0002490) | 1.93555626 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93043602 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 1.92862493 |
| 73 | Rectovaginal fistula (HP:0000143) | 1.92553898 |
| 74 | Rectal fistula (HP:0100590) | 1.92553898 |
| 75 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.92308015 |
| 76 | Epileptic encephalopathy (HP:0200134) | 1.91885836 |
| 77 | Synophrys (HP:0000664) | 1.91432054 |
| 78 | Generalized hypopigmentation (HP:0007513) | 1.90957744 |
| 79 | Optic nerve coloboma (HP:0000588) | 1.88909496 |
| 80 | Supernumerary spleens (HP:0009799) | 1.85953956 |
| 81 | Adrenal hypoplasia (HP:0000835) | 1.85567991 |
| 82 | Decreased central vision (HP:0007663) | 1.85389177 |
| 83 | Asymmetry of the thorax (HP:0001555) | 1.85315716 |
| 84 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.84350379 |
| 85 | Papillary thyroid carcinoma (HP:0002895) | 1.83744162 |
| 86 | Absent eyebrow (HP:0002223) | 1.83136531 |
| 87 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.81057134 |
| 88 | Morphological abnormality of the middle ear (HP:0008609) | 1.80447444 |
| 89 | Tubulointerstitial nephritis (HP:0001970) | 1.79309082 |
| 90 | Optic nerve hypoplasia (HP:0000609) | 1.77390174 |
| 91 | Limb dystonia (HP:0002451) | 1.76500843 |
| 92 | Impulsivity (HP:0100710) | 1.76103267 |
| 93 | Lissencephaly (HP:0001339) | 1.76021705 |
| 94 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75914048 |
| 95 | Chorioretinal coloboma (HP:0000567) | 1.75823768 |
| 96 | Nephronophthisis (HP:0000090) | 1.75559417 |
| 97 | Short tibia (HP:0005736) | 1.74756240 |
| 98 | Cerebral hypomyelination (HP:0006808) | 1.73400680 |
| 99 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.73386931 |
| 100 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.73322083 |
| 101 | Carpal bone hypoplasia (HP:0001498) | 1.73197319 |
| 102 | Morphological abnormality of the inner ear (HP:0011390) | 1.72708151 |
| 103 | Type 2 muscle fiber atrophy (HP:0003554) | 1.72022923 |
| 104 | Abnormality of the metopic suture (HP:0005556) | 1.71834653 |
| 105 | Increased hepatocellular lipid droplets (HP:0006565) | 1.71554335 |
| 106 | Abnormality of hair growth rate (HP:0011363) | 1.71403850 |
| 107 | Slow-growing hair (HP:0002217) | 1.71403850 |
| 108 | Septo-optic dysplasia (HP:0100842) | 1.71384849 |
| 109 | Intestinal fistula (HP:0100819) | 1.71146261 |
| 110 | Thyroid carcinoma (HP:0002890) | 1.71041964 |
| 111 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.70623585 |
| 112 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.70623585 |
| 113 | Broad foot (HP:0001769) | 1.70268905 |
| 114 | Postaxial hand polydactyly (HP:0001162) | 1.70105983 |
| 115 | Facial cleft (HP:0002006) | 1.67737328 |
| 116 | Astigmatism (HP:0000483) | 1.67359009 |
| 117 | Acute encephalopathy (HP:0006846) | 1.66135717 |
| 118 | Ocular albinism (HP:0001107) | 1.65611795 |
| 119 | Freckling (HP:0001480) | 1.65361023 |
| 120 | Melanoma (HP:0002861) | 1.63946645 |
| 121 | Poor head control (HP:0002421) | 1.61965420 |
| 122 | Spinal muscular atrophy (HP:0007269) | 1.60457527 |
| 123 | Abnormality of vision evoked potentials (HP:0000649) | 1.59382469 |
| 124 | Underdeveloped nasal alae (HP:0000430) | 1.58150947 |
| 125 | Lip pit (HP:0100267) | 1.57662251 |
| 126 | Megalencephaly (HP:0001355) | 1.56721864 |
| 127 | Alacrima (HP:0000522) | 1.52981931 |
| 128 | Aplasia cutis congenita (HP:0001057) | 1.52103687 |
| 129 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.44167816 |
| 130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.44167816 |
| 131 | Abnormality of glycolipid metabolism (HP:0010969) | 1.44167816 |
| 132 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.38655865 |
| 133 | Horizontal nystagmus (HP:0000666) | 1.34450983 |
| 134 | Melanocytic nevus (HP:0000995) | 1.33311197 |
| 135 | Leukodystrophy (HP:0002415) | 1.33109985 |
| 136 | Abnormality of the nasal septum (HP:0000419) | 1.31805092 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 1.30136087 |
| 138 | Ulnar claw (HP:0001178) | 1.28088659 |
| 139 | Fibular hypoplasia (HP:0003038) | 1.27303499 |
| 140 | Median cleft lip (HP:0000161) | 1.25781009 |
| 141 | Decreased lacrimation (HP:0000633) | 1.23884512 |
| 142 | Frequent falls (HP:0002359) | 1.19232186 |
| 143 | Visual hallucinations (HP:0002367) | 1.17954111 |
| 144 | Abnormality of the corticospinal tract (HP:0002492) | 1.14563167 |
| 145 | Upper limb muscle weakness (HP:0003484) | 1.12873205 |
| 146 | * Photophobia (HP:0000613) | 1.09427640 |
| 147 | Epidermoid cyst (HP:0200040) | 1.07235338 |
| 148 | Akinesia (HP:0002304) | 1.06918495 |
| 149 | Action tremor (HP:0002345) | 1.06092039 |
| 150 | Decreased motor nerve conduction velocity (HP:0003431) | 1.05275733 |
| 151 | Supernumerary nipples (HP:0002558) | 1.04967707 |
| 152 | Anophthalmia (HP:0000528) | 1.04743080 |
| 153 | Neoplasm of the oral cavity (HP:0100649) | 1.03943843 |
| 154 | Tongue fasciculations (HP:0001308) | 1.02088930 |
| 155 | Telecanthus (HP:0000506) | 1.01366390 |
| 156 | Nasal speech (HP:0001611) | 1.01146030 |
| 157 | Wide intermamillary distance (HP:0006610) | 0.99928640 |
| 158 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 0.98338229 |
| 159 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 0.98338229 |
| 160 | Hypopigmented skin patches (HP:0001053) | 0.98190957 |
| 161 | Hamartoma of the eye (HP:0010568) | 0.97338416 |
| 162 | Abnormality of the anterior chamber (HP:0000593) | 0.96816015 |
| 163 | Hypermetropia (HP:0000540) | 0.95787058 |
| 164 | Intestinal polyposis (HP:0200008) | 0.94509902 |
| 165 | Neoplasm of the peripheral nervous system (HP:0100007) | 0.92912323 |
| 166 | Vertebral compression fractures (HP:0002953) | 0.92496501 |
| 167 | Hypermelanotic macule (HP:0001034) | 0.91365468 |
| 168 | Long clavicles (HP:0000890) | 0.90556716 |
| 169 | Postural tremor (HP:0002174) | 0.89768880 |
| 170 | Intestinal polyp (HP:0005266) | 0.87542094 |
| 171 | Nasolacrimal duct obstruction (HP:0000579) | 0.86527080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.42834062 |
| 2 | PDK2 | 3.68119689 |
| 3 | AKT3 | 3.34982991 |
| 4 | SRPK1 | 2.78382582 |
| 5 | CCNB1 | 2.46416525 |
| 6 | SGK2 | 2.39078364 |
| 7 | ERBB3 | 2.31914264 |
| 8 | MKNK2 | 2.31357685 |
| 9 | YES1 | 2.28617725 |
| 10 | ZAK | 2.26332479 |
| 11 | MKNK1 | 2.24296357 |
| 12 | MAPK13 | 2.22543123 |
| 13 | STK16 | 2.19904567 |
| 14 | FER | 2.06236374 |
| 15 | MAP2K7 | 2.05736196 |
| 16 | ACVR1B | 2.04644512 |
| 17 | PLK2 | 2.03782906 |
| 18 | PRPF4B | 2.03291819 |
| 19 | BMPR2 | 2.01842616 |
| 20 | MAP3K3 | 1.97430672 |
| 21 | PLK3 | 1.90554400 |
| 22 | FGFR2 | 1.88718977 |
| 23 | SIK3 | 1.84119336 |
| 24 | PRKCH | 1.80528709 |
| 25 | PNCK | 1.77069594 |
| 26 | PLK4 | 1.68608299 |
| 27 | SGK223 | 1.65995028 |
| 28 | SGK494 | 1.65995028 |
| 29 | BUB1 | 1.65334559 |
| 30 | TRIM28 | 1.59186920 |
| 31 | BMPR1B | 1.57940713 |
| 32 | MST1R | 1.54337078 |
| 33 | VRK1 | 1.50955345 |
| 34 | MARK1 | 1.46879781 |
| 35 | EIF2AK1 | 1.44313399 |
| 36 | BRAF | 1.43835691 |
| 37 | CDK8 | 1.40574107 |
| 38 | NUAK1 | 1.40215200 |
| 39 | BCR | 1.36992563 |
| 40 | EPHA4 | 1.34594880 |
| 41 | GSK3A | 1.30885382 |
| 42 | MAP3K2 | 1.27336252 |
| 43 | WEE1 | 1.25781272 |
| 44 | SGK3 | 1.23527107 |
| 45 | DYRK2 | 1.22741983 |
| 46 | EIF2AK2 | 1.22272164 |
| 47 | DDR2 | 1.21699961 |
| 48 | EIF2AK3 | 1.20346086 |
| 49 | BRSK2 | 1.19723890 |
| 50 | STK38L | 1.18344873 |
| 51 | TGFBR1 | 1.15594367 |
| 52 | ADRBK2 | 1.13362116 |
| 53 | PTK2B | 1.12216434 |
| 54 | NEK6 | 1.08689940 |
| 55 | TYRO3 | 1.07562708 |
| 56 | CDK3 | 1.06784776 |
| 57 | ERBB2 | 1.05329054 |
| 58 | TSSK6 | 1.03589828 |
| 59 | BRSK1 | 1.02468362 |
| 60 | LATS1 | 1.02132359 |
| 61 | GRK7 | 1.00078997 |
| 62 | PINK1 | 0.96511197 |
| 63 | STK3 | 0.95963317 |
| 64 | FGFR1 | 0.95137569 |
| 65 | PRKD1 | 0.94916361 |
| 66 | CDK7 | 0.94540894 |
| 67 | NTRK2 | 0.91720706 |
| 68 | MAPKAPK3 | 0.91551599 |
| 69 | MARK3 | 0.91329782 |
| 70 | PRKD3 | 0.87417529 |
| 71 | TNIK | 0.85652322 |
| 72 | ABL2 | 0.85510185 |
| 73 | NME2 | 0.84354908 |
| 74 | STK24 | 0.83308190 |
| 75 | NEK2 | 0.83188317 |
| 76 | MAP3K12 | 0.82815529 |
| 77 | IRAK3 | 0.81937684 |
| 78 | AURKA | 0.81020691 |
| 79 | PAK4 | 0.80388342 |
| 80 | AKT2 | 0.79539227 |
| 81 | IRAK4 | 0.77048642 |
| 82 | MAP3K6 | 0.76579199 |
| 83 | MUSK | 0.76457116 |
| 84 | CHEK2 | 0.73909575 |
| 85 | PLK1 | 0.72034331 |
| 86 | MAP3K14 | 0.71913598 |
| 87 | LMTK2 | 0.70981199 |
| 88 | ADRBK1 | 0.69928432 |
| 89 | CSNK1G3 | 0.69487729 |
| 90 | FGR | 0.67103709 |
| 91 | NEK1 | 0.66285393 |
| 92 | PRKCE | 0.64308618 |
| 93 | PAK6 | 0.62308239 |
| 94 | NME1 | 0.61727857 |
| 95 | CDC7 | 0.61523132 |
| 96 | DYRK1A | 0.61068368 |
| 97 | TXK | 0.60324678 |
| 98 | PTK6 | 0.60120003 |
| 99 | NTRK3 | 0.59202781 |
| 100 | RPS6KB1 | 0.57899752 |
| 101 | UHMK1 | 0.57414611 |
| 102 | PKN1 | 0.57334452 |
| 103 | PRKCG | 0.56741389 |
| 104 | PAK3 | 0.56219193 |
| 105 | GRK6 | 0.55325257 |
| 106 | MATK | 0.54974164 |
| 107 | RPS6KC1 | 0.54933951 |
| 108 | RPS6KL1 | 0.54933951 |
| 109 | ARAF | 0.51440193 |
| 110 | MINK1 | 0.51081009 |
| 111 | RPS6KA6 | 0.50194826 |
| 112 | MET | 0.49732646 |
| 113 | CSNK1G2 | 0.49728088 |
| 114 | CSNK1G1 | 0.49579073 |
| 115 | INSRR | 0.49072403 |
| 116 | FRK | 0.48405068 |
| 117 | TGFBR2 | 0.47781570 |
| 118 | OXSR1 | 0.47720480 |
| 119 | RPS6KA2 | 0.46677406 |
| 120 | CAMK2B | 0.45814765 |
| 121 | EPHA3 | 0.45649890 |
| 122 | WNK3 | 0.45121072 |
| 123 | CSNK1D | 0.44839400 |
| 124 | TIE1 | 0.44721916 |
| 125 | TAF1 | 0.44675699 |
| 126 | PRKACB | 0.44480692 |
| 127 | CSNK2A1 | 0.43822017 |
| 128 | MAP3K4 | 0.42917586 |
| 129 | MAP2K1 | 0.41850630 |
| 130 | CSNK1A1L | 0.41687354 |
| 131 | PBK | 0.41413920 |
| 132 | GRK5 | 0.40622763 |
| 133 | CDK6 | 0.40307639 |
| 134 | TAOK2 | 0.39072500 |
| 135 | DAPK1 | 0.37579849 |
| 136 | CDK18 | 0.36815651 |
| 137 | MAPKAPK5 | 0.36435982 |
| 138 | RPS6KA5 | 0.36173829 |
| 139 | TNK2 | 0.35636391 |
| 140 | CSNK1A1 | 0.35385494 |
| 141 | ATM | 0.34899790 |
| 142 | MAP3K11 | 0.34447713 |
| 143 | KIT | 0.33366496 |
| 144 | CAMK2A | 0.33247962 |
| 145 | ATR | 0.32731213 |
| 146 | IRAK2 | 0.32578287 |
| 147 | CLK1 | 0.32243174 |
| 148 | MYLK | 0.32079612 |
| 149 | PRKAA2 | 0.31755380 |
| 150 | GRK1 | 0.31544031 |
| 151 | SGK1 | 0.31251255 |
| 152 | CDK14 | 0.31113498 |
| 153 | CDK15 | 0.30666949 |
| 154 | ERBB4 | 0.29433017 |
| 155 | ICK | 0.29255386 |
| 156 | CHUK | 0.28008583 |
| 157 | CDK11A | 0.27402791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.72239250 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.17616724 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 2.68527993 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.27139627 |
| 5 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.26202601 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.26015908 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.22546803 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.22214234 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.21754909 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.15150972 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.08869235 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.07661823 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.02107091 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.96885096 |
| 15 | RNA degradation_Homo sapiens_hsa03018 | 1.95312639 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88736690 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.87254223 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.80842977 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.74952372 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.72851511 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66381713 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65792852 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 1.61747332 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.60081350 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.59032567 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.58162130 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.57357539 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.51981832 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51195167 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.48959326 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45123179 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43183121 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.41213773 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.39755257 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39236886 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.35188745 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35024067 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33100385 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31313164 |
| 40 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.28938923 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28672109 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23901713 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20620064 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.19618338 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.15677114 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14156860 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.13125475 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10716218 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07618449 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07575584 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.04524231 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 1.03568476 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00796875 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97634520 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.95485111 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.94138638 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92541947 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89938745 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.88369722 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86988685 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.86943081 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86460225 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85572415 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.83167310 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81279678 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81274300 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78445202 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76802774 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76719305 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75280072 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75032356 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74597002 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72878926 |
| 74 | GABAergic synapse_Homo sapiens_hsa04727 | 0.72654232 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70416734 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70414714 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70139012 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68368596 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68247723 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67306741 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.66671470 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66453575 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65050756 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63488285 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.63098061 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.62481273 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60669274 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60506635 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.60135608 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59718387 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59013906 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58787569 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57135043 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56325538 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.55469751 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54847822 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54676077 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52053572 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51825093 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51401155 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51134196 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50371560 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49786849 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49062819 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48670560 |
| 106 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47106680 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46599112 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45821743 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45354660 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44871621 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44401179 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.44321457 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44067507 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.40563009 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40552000 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40360770 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39874069 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39659845 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.36983033 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36850667 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36014352 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35966110 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35662784 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34700206 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34162265 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33245633 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33178974 |
| 128 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32217046 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31937295 |
| 130 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31012630 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30351708 |
| 132 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.29496523 |
| 133 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29419131 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29201296 |
| 135 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28964810 |
| 136 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28739299 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28334724 |
| 138 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26328351 |
| 139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23094293 |
| 140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22432895 |
| 141 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22362218 |
| 142 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22251516 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21683875 |

